Orbital inflammatory disease following mRNA SARS-CoV-2 vaccine.

Solange GrunenwaldGabriel LethellierPhilippe ImbertCéline DekeisterPhilippe J Caron

Published in: Clinical case reports (2022)

A 65-year-old woman reported orbital symptoms two days after her first dose and presented exacerbation of signs after the second dose of BNT162b2 mRNA vaccine. The temporal relationship between the COVID-19 vaccination and orbital symptoms suggests a probable link between SARS-CoV-2 mRNA vaccine and this orbital inflammatory disease.

Keyphrases

sars cov
respiratory syndrome coronavirus
oxidative stress
binding protein
chronic obstructive pulmonary disease
coronavirus disease